ANUVA

Caucasians comprise 4 in 5 of available genomic sequences for analysis. This data is way too homogeneous. Know more about the problem arising out of this limited diversity and what Anuva is doing about it... Collecting genomic data from diverse populations as well as blending it with data on disease traits to create richer interpretation are both specializations in themselves. Rather than work on data, can drug discovery teams get a partner who can provide what they need?... As the science community embarks on a genomics-led revolution in drug discovery and development, it is helpful to take a bird's-eye view of where we stand now.

Primary location: Southampton United Kingdom